FDA Consumer Information
On April 7, 2016, the Food and Drug Administration has published a Consumer Update titled “Biosimilars: More Treatment Options Are on the Way.” The easy-to-read primer incorporates quotes from Leah Christl, PhD, Associate Director for Therapeutic Biologics at FDA.
Among the topics covered in the Consumer Update are the differences between biologics and conventional medications, basic information about biosimilars, and specific information about Inflectra. The article also explains that with an increasing number of biosimilars on the market, consumers may expect to get equally safe and effective treatment, but at lower costs.
The Consumer Update is available on the FDA website at http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm436399.htm.